[Therapeutic studies with branched-chain amino acids in portasystemic encephalopathy].
Published controlled clinical trials with branched chain amino acids (BCAA) in patients with portosystemic encephalopathy (PSE) are described and their results discussed. A positive effect on PSE by BCAA seems probable but without altering mortality rate. Improvement of nutritional state cannot be finally evaluated.
Egberts
E H
EH
Medizinische Universitätsklinik Tübingen.
D000597:Amino Acids, Branched-Chain / Q000008:administration & dosage*; D002986:Clinical Trials as Topic; D004044:Dietary Proteins / Q000008:administration & dosage; D006501:Hepatic Encephalopathy / Q000178:diet therapy*; D006801:Humans
D000597:Amino Acids, Branched-Chain; D004044:Dietary Proteins
Therapeutische Studien mit verzweigtkettigen Aminosäuren bei portosystemischer Enzephalopathie.